Restarting Thalidomide-Dexamethasone regimen in a Post-Abortive female with multiple myeloma: Effective clinical response possible

Rehman, S. and Arif, S.H. and Kumar, A. and Khan, A.Q. (2017) Restarting Thalidomide-Dexamethasone regimen in a Post-Abortive female with multiple myeloma: Effective clinical response possible. International Journal of Hematology-Oncology and Stem Cell Research, 11 (4). pp. 301-304. ISSN 17351243

Full text not available from this repository.
Official URL: http://ijhoscr.tums.ac.ir/index.php/ijhoscr/articl...

Abstract

Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidomide-Dexamethasone therapy in a post-abortive woman with persistently elevated β-hCG levels due to retained products of conception, undergoing hysterectomy later. This case report underlines the clinical significance of age, the effect of Thalidomide-Dexamethasone therapy even after initial discontinuation and the response to high β-hCG levels.

Item Type: Article
Uncontrolled Keywords: High β-hCG levels; Multiple myeloma; Post-aborted woman; Thalidomide-dexamethasone therapy
Subjects: R Medicine > R Medicine (General)
Divisions: Faculties > Faculty of Medicine
Depositing User: AMU Library
Date Deposited: 29 Jan 2018 05:48
Last Modified: 01 Feb 2018 05:48
URI: http://ir.amu.ac.in/id/eprint/10993

Actions (login required)

View Item View Item